- |||||||||| LiRIS (lidocaine) / J&J
Journal: Pest categorisation of Liriomyza sativae. (Pubmed Central) - Sep 4, 2020
sativae (the cabbage or vegetable leaf miner; EPPO code: LIRISA) is a polyphagous pest native to the Americas which has spread to Africa, Asia and Oceania...sativae satisfies the criteria that are within the remit of EFSA to assess for it to be regarded as a potential Union quarantine pest. Although human-assisted movement of vegetables is considered the main spread way for L. sativae, this agromyzid does not meet the criterion of occurring in the EU for it to be regarded as a potential Union regulated non-quarantine pest.
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial completion: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Jan 23, 2018
P2, N=62, Completed,
Although human-assisted movement of vegetables is considered the main spread way for L. sativae, this agromyzid does not meet the criterion of occurring in the EU for it to be regarded as a potential Union regulated non-quarantine pest. Active, not recruiting --> Completed
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment closed, Trial primary completion date: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Sep 13, 2017
P2, N=62, Active, not recruiting,
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Jun 2017
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial completion: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Sep 8, 2017
P2, N=131, Completed,
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Jun 2017 Active, not recruiting --> Completed
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial primary completion date: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Dec 14, 2016
P2, N=76, Recruiting,
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Nov 2017
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment closed: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Aug 19, 2016
P2, N=116, Active, not recruiting,
Trial primary completion date: Dec 2016 --> Nov 2017 Recruiting --> Active, not recruiting
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial primary completion date: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Aug 8, 2016
P2, N=76, Recruiting,
Recruiting --> Active, not recruiting Trial primary completion date: Jul 2016 --> Dec 2016
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial primary completion date: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Jan 25, 2016
P2, N=76, Recruiting,
Trial primary completion date: Jul 2016 --> Dec 2016 Trial primary completion date: Jun 2017 --> Jul 2016
- |||||||||| LiRIS (lidocaine) / AbbVie
Trial primary completion date: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Jan 19, 2016
P2, N=76, Recruiting,
Trial primary completion date: Jun 2017 --> Jul 2016 Trial primary completion date: Aug 2016 --> Jun 2017
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment open: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - Jul 14, 2015
P2, N=116, Recruiting,
Trial primary completion date: Aug 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment change, Trial termination: Safety, Tolerability and Efficacy Study of LiRIS (clinicaltrials.gov) - Jun 11, 2015
P2, N=30, Terminated,
Not yet recruiting --> Recruiting N=124 --> 30 | Active, not recruiting --> Terminated; This study was terminated early due to company decision.
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment open: A Safety and Efficacy Study of LiRIS (clinicaltrials.gov) - May 14, 2015
P2, N=76, Recruiting,
N=124 --> 30 | Active, not recruiting --> Terminated; This study was terminated early due to company decision. Not yet recruiting --> Recruiting
- |||||||||| LiRIS (lidocaine) / AbbVie
Enrollment closed: Safety, Tolerability and Efficacy Study of LiRIS (clinicaltrials.gov) - Nov 25, 2014
P2, N=124, Active, not recruiting,
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
|
